Charles Conway
Keine laufenden Positionen mehr
Karriereverlauf von Charles Conway
Ehemalige bekannte Positionen von Charles Conway
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Direktor/Vorstandsmitglied | - | 03.10.2022 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 03.10.2022 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2000 | 01.01.2017 |
Ausbildung von Charles Conway
| University of California San Diego | Graduate Degree |
| University of Central Missouri | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Börse
- Insiders
- Charles Conway
- Erfahrung
